Showing results (401-410 of 445) with videos related to

Sort By:
Pageof 45
Journal of the Neurological Sciences|May 31, 2011
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohortC Ryberg, E Rostrup, O B Paulson, et al.
The Oncologist|April 13, 2013
Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancerBrian M Wolpin, Kimmie Ng, Andrew X Zhu, et al.
Allergy|May 3, 2017
Amb a 1 isoforms: Unequal siblings with distinct immunological featuresM Wolf, T E Twaroch, S Huber, et al.
ESMO Open|November 19, 2025
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 studyJ-P Metges, K Kato, J-M Sun, et al.
Nature Communications|January 12, 2022
Following excited-state chemical shifts in molecular ultrafast x-ray photoelectron spectroscopyD Mayer, F Lever, D Picconi, et al.
The Lancet. Oncology|October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 studyZev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
JCO Precision Oncology|January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal CancerRachel B Keller, Tali Mazor, Lynette Sholl, et al.
Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.
The Lancet. Oncology|November 26, 2009
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 studyAndrew X Zhu, Jeffrey A Meyerhardt, Lawrence S Blaszkowsky, et al.
Alcoholism, Clinical and Experimental Research|April 1, 2006
Basis of the gabamimetic profile of ethanolG R Breese, H E Criswell, M Carta, et al.
Pageof 45